Sickle Cell Disease

New Sickle Cell Drug Boasts Impressive Hospitalization & Crises Data!

Sickle cell disease is one of the most common inherited blood disorders, affecting about 100,000 Americans, most of them black, and about ... Read More

Care Coordination For Sickle Cell Disease With Dr. Lewis Hsu (Video)

BDO got the opportunity to attend the Sickle Cell Disease Association of Illinois' 2019 Management of Sickle Cell Disease Conference. Here, ... Read More

The Importance Of Movement & Healthy Diet For Sickle Cell Disease (Video)

BDO attended The SCDAA 47th Annual National Conference and we got a chance to speak with Dr. Carolyn Rowley, Founder and Executive ... Read More

How Does Sickle Cell Disease Really Affect Families? (Video)

BDO attended the SCDAA 47th Annual National Conference and we got a chance to speak with 2019 SCDAA Child Ambassador Kiarra Roseburg and ... Read More

Living Long And Well With Sickle Cell Disease (Video)

BDO attended the SCDAA 47th Annual National Conference and we got a chance to speak with Wanda Williams, who is a 70-year-old ... Read More

New Treatments For Sickle Cell Disease (Video)

James Eckman, MD discusses new treatments and what the future might hold for Sickle Cell Disease patients! This seminar was filmed live ... Read More

Sickle Cell & Flu Shots: Facts You Don’t Know

Common illnesses, like the flu, can quickly become dangerous, especially for a person with sickle cell disease. Studies have shown that ... Read More

FDA Issues Accelerated Approval For New Sickle Cell Drug, Oxbryta

The U.S. Food and Drug Administration granted accelerated approval to Oxbryta (voxelotor) for the treatment of sickle cell disease (SCD) in ... Read More

Breakthrough Treatment: Gene Therapy For Sickle Cell Disease (Video)

We're live from The SCDAA 47th Annual National Conference in Baltimore, MD! This seminar, led by Julie Kanter, MD, discusses gene therapy ... Read More

New Sickle Cell Drug, ADAKVEO, Approved!

The U.S. Food and Drug Administration (FDA) approved Novartis’ Adakveo (crizanlizumab) to decrease the frequency of pain crises, in adults ... Read More